Thanks for detailed and thorough article. Very helpful and plenty of useful information. Even if one doesn't follow the outlined strategy to a T, there's good info in stocks to buy, and other instruments.
If I could rewind time, I'd go to just before covid hit and invest into a large range of biotech firms, and also large online retailers, and then a bunch into AI related stocks.
RedHill secures funding for Phase 2 study of COVID-19 treatment
RedHill said it has received new non-dilutive external funding for a Phase 2 study of its oral antiviral drug RHB-107 in the treatment of early COVID-19. The Israeli company said the approximately $4.8M in funding will cover the entirety of the RHB-107 arm of the ACESO PROTECT study for early COVID-19 outpatient treatment. The study, which will have 300 patients, is expected to begin enrollment in the coming weeks and be completed by the end of 2024. If approved, the product could provide an additional option to Pfizer’s Paxlovid in the early COVID-19 treatment space, RedHill said. More on RedHill RedHill stock nearly doubles in value pre-market on a five-year FDA exclusivity grant Financial information for RedHill